I share the concerns expressed by Wright, Ridley and Morgan writing in the July issue of JICS. 1 While supporting the broader aims of the Organ Donation Task Force (ODTF), I do take issue in the way that the taskforce recommendations are being implemented with particular regard to the appointment process for Clinical Leads for Organ Donation (CLODs) and the plans to increase the numbers of non-heart-beating donors.
As far as I am aware, it was never the intention of the ODTF that the posts of clinical leads should be offered preferentially to consultants with an interest in critical care medicine, nor that expressions of interest should primarily come from the latter. Indeed the person specification states 'A medical or nursing qualification and experience of working at consultant level or equivalent in critical care medicine or another appropriate discipline'. When the CLOD is an active intensivist, there is concern regarding conflict of interest, especially in relation to the drive to expand the non-heart beating donor programme. Given that the role is remunerated, the incumbent is likely to fulfill the ideals of the ODTF recommendations without recourse to any reservations expressed by interested parties.
I also have concerns about the drive to narrow the gap between our duty of care to the individual patient and their best interests and that of the wider benefit to the population as a whole. Colleagues may feel pressurised to refer patients as potential donors even in the absence of a clear decision to withdraw supportive treatment. There is also a danger that the suggestion of empowering critical care nursing staff to notify the donor co-ordinator about potential patients may jeopardise the important layers of trust that exist between medical and nursing staff, and patients and their families.
There is confusion among many colleagues who believe that we are mandated to inform the transplant co-ordinator about all patients in whom we may consider withdrawal of treatment. Specifically, ODTF report recommendation 4 states that: 'Discussions about donation should be part of all end of life care when appropriate'. 2 The critical care team is best placed to make that judgment as to when to refer.
The endorsement of the ODTF recommendations by our professional bodies may lead to reluctance by colleagues to raise concerns. Similarly, with the majority of the organ donation clinical leads coming from a critical care background, there may be a reluctance to voice concerns in deference to a colleague' s position as the CLOD.
It will only take one or two high-profile cases, with moral, ethical and indeed legal ramifications, to set back the whole ODTF programme. While the solutions suggested by the authors are plausible, it could be argued that CLODs should only be appointed from those who do not actively practise critical care medicine, thus maintaining a healthy distance between our duty of care to the critically ill and the wider aims of the ODTF in improving the availability of organs for transplant.
No doubt with time, many of these issues will be addressed and guidance modified, but I think it is imperative that the critical care community voices its concerns and retains an influence in shaping the interpretation and implementation of the ODTF guidance.
These are personal views and not necessarily representative of my critical care colleagues.
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John Gannon Consultant Intensivist, Wirral University
Teaching Hospital john.gannon@nhs.net W e read with interest and some concern the letter by Drs
Wright, Ridley and Morgan. 1 While acknowledging that they raise relevant issues, it is regrettable that they miss the philosophy that supports organ donation in the critical care environment.
A clinical lead is someone who can lead the clinical process and preferably has experience of doing so. We believe that intensivists in UK hospitals are well placed to lead this process. There is a need to understand that the debate here is between 'utilitarian rationalism' and 'moral neutrality' as described by Streat. 2 In the former, the encounter regarding organ donation is seen as part of transplant organ procurement, driven primarily by the needs of transplant recipients and secondly by any positive views about organ donation previously expressed by the now-deceased. The desired outcome in this paradigm is organ donation. However, the authors clearly do not see the other view of moral neutrality, where the encounter is a part of end-of-life care in the intensive care unit (ICU). That process is driven by the needs of the donor family and by the principles of informed consent. It encompasses discussion of all relevant issues (including any views about organ donation previously expressed by the now-deceased) but the desired outcome is good process (which may or may not include organ donation).
Facilitating patients' aspirations and previous wishes to donate is an important consideration for every ICU clinician. An important feature during the process of facilitating end-oflife care in the ICU must be the determination of what is in the patient' s best interest. All UK ICU clinicians would seek the opinion of the family as a surrogate expression of the patients' own opinion, if they were able to provide such an opinion. Section 4[6] of the Mental Capacity Act [2005] 3 clearly states that such best interests must take into account any previously held views not confined to medical matters. Surely, a previously expressed desire to donate organs or tissues or the family' s expression of such an interest on the patient' s behalf should be part of that exploration of what the patient might have wished.
There is a suggestion that the remuneration received for the work of Clinical Lead for Organ Donation (CLOD) would persuade CLODs to alter their behaviour. These are Trust appointments, with commissioning arrangements between NHSBT and individual Trusts, and not with individual clinicians. This is not a matter of perspective: it is an exact and defined arrangement.
Remuneration for the clinical lead reflects the leadership role of the individual, and is not linked to individual rates of donation. It seems to suggest that only CLODs will be involved in these important decisions that are being made, and not the wider healthcare team, as recommended. 4 All critical care practitioners will be guided by the GMC' s guidance on end-oflife care 4 combined with the DH guidance on the issue. 5 It is quite another matter that both these documents refer to the consideration of organ donation in patients when appropriate. Indeed, one of the consequences of CLODs being appointed is their role in ensuring that there must be a clear separation between the withdrawal of life-sustaining treatment when appropriate and the discussions about organ donation that follow. Individual CLODs will be less vulnerable to accusations of conflict of interest where an end-of-life decision has been clearly documented as having been a multidisciplinary one. The remuneration following transplantation does not pass to CLODs but to the NHS Trust, and reflects the increased costs to the organisation for such a process.
It must also be understood that along with the appointment of CLODs, hospitals have also appointed Donation Committees that are actually responsible for overseeing the work of organ donation in each organisation. A CLOD is a member of this wider group. Donation Committees have representatives of patient groups, spiritual leaders as well as medical and nursing professionals drawn from the hospital. Therefore, the Committee ensures that not only are robust mechanisms in place in every hospital, but that there is a direct governance link to the organisation.
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W e were interested to read the letter from Wright, Ridley and Morgan in the July edition of JICS 1 regarding a potential conflict of interest between the roles of 'Clinical Lead for Organ Donation' (CLOD) and 'Intensive Care Consultant.' We agree with the authors that the introduction of CLODs has served to underpin a very deserving causethat of increasing the number of organs transplanted in the UK, thereby decreasing the number of people dying on transplant waiting lists. We also agree that establishing governance around the CLOD role is an important issue requiring careful discussion and consensus. However, we strongly disagree with the basis for a potential conflict of interest as described.
In our institution, both donation after brainstem death and donation after cardiac death occur as part of the usual end-of-life pathway within critical care. There can be no conflict of interest because the potential for organ donation is explored in all deaths. It is the end-of-life care including events after legal death that takes precedence, whether donation occurs or not. Our management of potential donors after cardiac death is the same whether they donate or not, and we emphasise this to the next-of-kin and to members of the multidisciplinary team. In brainstem dead patients who may be candidates for organ donation, we again prioritise the dignity of the patient who has died (as well as their known or probable wishes) and the feelings of their loved ones. We agree with the authors that a second opinion about treatment limitation is desirable, but believe that this is because it is good practice for withdrawal decision-making/end-of-life care as a whole and should not just be reserved for those in whom Comment JICS Volume 11, Number 4, October 2010 D onation and transplantation give rise to many situations in which medical professionals have to balance complex and conflicting interests. While those working within critical care largely face those relating to donation, transplant clinicians face similar dilemmas when confronted with the urgent needs of potential recipients. While the families of organ donors can derive considerable comfort from agreeing to donation, it remains imperative that everyone involved, in particular the family, remain confident that the patient' s interests are protected, whatever their donor status or outcome.
Wright et al 1 suggest that, wherever possible, the clinician overseeing the care of a potential organ donor should not be the same person with the responsibility of Clinical Lead for Organ Donation (CLOD), and the two roles should remain separate, otherwise the consultant' s professional judgment and duty of care to patients might be, or might appear to others to be, unduly influenced by a desire to increase organ donation rates.
Guidance from the General Medical Council 2 reminds us that all doctors have a binding duty to act in a patient' s best interests, and cautions against other considerations which may either influence, or be seen to influence, their judgement. Where a dying patient for whom further treatment is futile is a registered donor, it becomes part of their 'best interest' consideration that donation proceed. Where a patient' s wishes are unclear, it is still in their and their family' s best interest to establish how to proceed in relation to donation. Where a patient or their family clearly do not wish to consider donation, this wish must be respected.
Success in organ donation is critically dependent upon patients and families establishing trusting relationships with the clinical staff caring for the dying, and understanding and having confidence in the donation process. The strategic objective of CLODs is to ensure that all clinical staff give their patients the opportunity to donate. Furthermore, critical care consultants with this dual role may be uniquely placed to accompany a family, and have the opportunity to demonstrate through their actions that there is no such conflict, perceived or otherwise, between their obligations to a patient and their family and their local strategic role in donation. However, they should be alert to situations in which conflicts of interest may arise, or be perceived to arise, and through the development of appropriate local policies take sensible measures to minimise or avoid them. Their actions must be open, objective, justifiable and free from self-interest, especially in circumstances where ethical boundaries are blurred. Guidance and practice around these issues should be regularly reviewed.
We are grateful to all those who have taken on the challenging role of CLOD and continue to support them by providing training and professional support.
